Full-Time

Project Finance Analyst 1

Posted on 8/6/2025

Altasciences

Altasciences

1,001-5,000 employees

Integrated CRO for early-phase drug development

No salary listed

Overland Park, KS, USA

In Person

Category
Finance & Banking (1)
Required Skills
Financial analysis
Word/Pages/Docs
Excel/Numbers/Sheets
PowerPoint/Keynote/Slides
Requirements
  • Bachelor’s degree in accounting or related field preferred or equivalent work experience.
  • Minimum of 1-year of related experience is preferred.
  • Excellent verbal and written communication skills.
  • Good interpersonal skills.
  • Critical thinking, initiative and good judgement as well as constructive problem solving.
  • Ability to set priorities and work in an organized manner.
  • Strong attention to detail.
  • Professional demeanor, including the ability to demonstrate the upmost discretion pertaining to employee information.
  • Proven ability to work as part of a team in a very fast paced, deadline-driven environment.
  • Strong MS Office skills including Word, Excel, PowerPoint and Outlook and familiarity with HRMS systems.
Responsibilities
  • Load project budgets to financial management systems. Review / reconcile loaded project budgets to ensure accuracy against contracted values.
  • Load payment schedule to financial management systems. Review / reconcile loaded project payment schedule to ensure accuracy against contracted values and compliance to negotiated contract terms.
  • Maintain configuration of Project and Contract modules, including assignment of Rate Sets / Plans to Activities and configuration of Contract Lines.
  • Prepares project level actual versus budget/forecast variance analysis monthly as well as monthly reports for distribution in analyzing monthly results.
  • Conduct monthly review and analysis of assigned projects, including review of revenue recognition, project performance variances, and WIP/Deferred revenue positions.
  • Perform project level WIP/Deferred revenue reconciliations as required.
  • Monitor WIP/Deferred revenue, over the Limit and Contract activation reports and resolve/escalate unusual activity.
  • Prepare monthly reporting requirements for assigned projects, including unsigned contract opportunities, backlog, and other ad-hoc financial analysis as required.
  • Work with project management to ensure accurate projections taking into consideration changing project timelines, changes in scope and budget to actual comparisons which may require change orders.
  • Responsible for ensuring that payments do not exceed SOW timelines.
  • Responsible for ensuring change orders are executed and communicated to appropriate personnel.
  • Act as a central contact for the project team for designated project communications, correspondence and associated documentation.
  • Participate in (study) team meetings/Project kick off meetings and interaction with cross functional staff to verify information and/or triage new data issues or prior identified action items.
Desired Qualifications
  • Bachelor’s degree in accounting or related field preferred or equivalent work experience.
  • Minimum of 1-year of related experience is preferred.

Altasciences provides an integrated CRO that handles the full early‑phase drug development path, from preclinical testing through clinical proof of concept and into manufacturing. Its approach combines discovery support, safety testing, clinical trial execution, and in‑house manufacturing to run programs under one roof. This contrasts with competitors that require pharma and biotech clients to source services from multiple vendors, adding complexity and risk; Altasciences streamlines the process by coordinating all steps. The company aims to help innovator drug programs move quickly and efficiently, delivering integrated data to de‑risk decisions and speed progression to later stages.

Company Size

1,001-5,000

Company Stage

Early VC

Total Funding

$6.7M

Headquarters

Laval, Canada

Founded

1976

Simplify Jobs

Simplify's Take

What believers are saying

  • Biotech/pharma consolidation demand for single-vendor early-phase development solutions increases.
  • 3D tissue technology adoption reduces animal testing costs and accelerates regulatory approval timelines.
  • Geographic footprint and participant database enable rapid enrollment for mid-size biopharma sponsors.

What critics are saying

  • Novo Holdings divesting Altasciences signals poor financial performance and operational cutbacks.
  • Charles River aggressive pricing on integrated packages captures 20% mid-size biopharma contracts.
  • AI-driven preclinical platforms from Insilico Medicine displace traditional animal safety pharmacology testing.

What makes Altasciences unique

  • Integrated CRO/CDMO spanning preclinical safety testing through Phase IV bioanalysis and manufacturing.
  • 9 North American facilities with 500,000+ participant database conducting 285+ trials annually.
  • VoxCell partnership integrates 3D tissue technology for human-relevant preclinical testing.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

401(k) Company Match

Paid Vacation

Paid Sick Leave

Paid Holidays

Employee Assistance & Telehealth Programs

Remote Work Options

Company News

GlobeNewswire
Mar 16th, 2026
Outlook Therapeutics Announces New $18.4 Million Non-Convertible Note Financing and Amendment to Existing Convertible Note

ISELIN, N.J., March 16, 2026 (GLOBE NEWSWIRE) -- Outlook Therapeutics, Inc. (Nasdaq: OTLK), a biopharmaceutical company focused on enhancing the standard...

Business Wire
Aug 20th, 2025
Altasciences Receives EcoVadis Gold Medal for Environmental, Social, and Governance (ESG) Efforts

EcoVadis, the world's most trusted provider of business sustainability ratings, has collaborated closely with Altasciences to enhance its environmental, social, and governance (ESG) initiatives, underscoring the company's commitment to a sustainable future and a reduced environmental footprint.

Yahoo Finance
Jul 31st, 2025
Altasciences and VoxCell BioInnovation Announce Strategic Collaboration to Advance Preclinical Drug Development

This partnership combines Altasciences' comprehensive early-phase drug development capabilities with VoxCell's cutting-edge 3D tissue technology to offer a more predictive and human-relevant preclinical testing environment.

Postmedia Network
Mar 28th, 2025
Altasciences Receives 2025 CDMO Leadership Award in Small Molecule Dosage Form Category

For 14 years, Outsourced Pharma's CDMO Leadership Awards have recognized the top-performing contract development and manufacturing organizations based on comprehensive industry research, and feedback from sponsors.

BioSpace
May 29th, 2024
Altasciences Receives 2024 CRO Leadership Award for Capabilities

Altasciences receives 2024 CRO Leadership Award for Capabilities.

INACTIVE